Pulse Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLSE and other ETFs, options, and stocks.

About PLSE

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. 

CEO
Paul A. LaViolette
CEOPaul A. LaViolette
Employees
116
Employees116
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
2014
Founded2014
Employees
116
Employees116

PLSE Key Statistics

Market cap
1.37B
Market cap1.37B
Price-Earnings ratio
-18.63
Price-Earnings ratio-18.63
Dividend yield
Dividend yield
Average volume
275.47K
Average volume275.47K
High today
$20.16
High today$20.16
Low today
$19.00
Low today$19.00
Open price
$19.07
Open price$19.07
Volume
273.03K
Volume273.03K
52 Week high
$26.30
52 Week high$26.30
52 Week low
$12.56
52 Week low$12.56

Stock Snapshot

As of today, Pulse Biosciences(PLSE) shares are valued at $19.70. The company's market cap stands at 1.37B, with a P/E ratio of -18.63.

On 2026-04-15, Pulse Biosciences(PLSE) stock traded between a low of $19.00 and a high of $20.16. Shares are currently priced at $19.70, which is +3.7% above the low and -2.3% below the high.

Pulse Biosciences(PLSE) shares are trading with a volume of 273.03K, against a daily average of 275.47K.

In the last year, Pulse Biosciences(PLSE) shares hit a 52-week high of $26.30 and a 52-week low of $12.56.

In the last year, Pulse Biosciences(PLSE) shares hit a 52-week high of $26.30 and a 52-week low of $12.56.

PLSE News

Simply Wall St 2d
Assessing Pulse Biosciences Valuation After Leadership Changes To Advance nPulse Cardiac Ablation System

Pulse Biosciences (PLSE) has refreshed its leadership team by appointing Liane Teplitsky as Chief Operating Officer and expanding Dr. David Kenigsberg’s role as...

Assessing Pulse Biosciences Valuation After Leadership Changes To Advance nPulse Cardiac Ablation System
TipRanks 6d
Pulse Biosciences appoints new COO to advance commercialization

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Nasdaq 6d
Pulse Biosciences Appoints Liane Teplitsky CCO, Expands David Kenigsberg Role As Full Time CMO

(RTTNews) - Pulse Biosciences, Inc. (PLSE), a bioelectric medicine company, Thursday, announced the appointment of Liane Teplitsky as Chief Operating Officer....

Pulse Biosciences Appoints Liane Teplitsky CCO, Expands David Kenigsberg Role As Full Time CMO

People also own

Based on the portfolios of people who own PLSE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.